249 related articles for article (PubMed ID: 38632185)
41. Cholesterol 25-hydroxylase (CH25H) as a promoter of adipose tissue inflammation in obesity and diabetes.
Russo L; Muir L; Geletka L; Delproposto J; Baker N; Flesher C; O'Rourke R; Lumeng CN
Mol Metab; 2020 Sep; 39():100983. PubMed ID: 32229247
[TBL] [Abstract][Full Text] [Related]
42. [Role of chronic inflammation in adipose tissue in the pathophysiology of obesity].
Suganami T; Ogawa Y
Nihon Rinsho; 2013 Feb; 71(2):225-30. PubMed ID: 23631197
[TBL] [Abstract][Full Text] [Related]
43. Adipose stress-sensing kinases: linking obesity to malfunction.
Rudich A; Kanety H; Bashan N
Trends Endocrinol Metab; 2007 Oct; 18(8):291-9. PubMed ID: 17855109
[TBL] [Abstract][Full Text] [Related]
44. Insulin resistance, weight, and behavioral variables as determinants of brain reactivity to food cues: a Prevention of Diabetes through Lifestyle Intervention and Population Studies in Europe and around the World - a PREVIEW study.
Drummen M; Dorenbos E; Vreugdenhil ACE; Raben A; Westerterp-Plantenga MS; Adam TC
Am J Clin Nutr; 2019 Feb; 109(2):315-321. PubMed ID: 30590423
[TBL] [Abstract][Full Text] [Related]
45. Adipose tissue angiogenesis in obesity.
Lemoine AY; Ledoux S; Larger E
Thromb Haemost; 2013 Oct; 110(4):661-8. PubMed ID: 23595655
[TBL] [Abstract][Full Text] [Related]
46. Perivascular adipose tissue, inflammation and insulin resistance: link to vascular dysfunction and cardiovascular disease.
Lastra G; Manrique C
Horm Mol Biol Clin Investig; 2015 Apr; 22(1):19-26. PubMed ID: 25941914
[TBL] [Abstract][Full Text] [Related]
47. Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ.
Calabro P; Yeh ET
Subcell Biochem; 2007; 42():63-91. PubMed ID: 17612046
[TBL] [Abstract][Full Text] [Related]
48. Potential of Nutraceutical Supplementation in the Modulation of White and Brown Fat Tissues in Obesity-Associated Disorders: Role of Inflammatory Signalling.
Scarano F; Gliozzi M; Zito MC; Guarnieri L; Carresi C; Macrì R; Nucera S; Scicchitano M; Bosco F; Ruga S; Coppoletta AR; Mollace R; Maiuolo J; Bava I; Cardamone A; Ragusa M; Palma E; Musolino V; Mollace V
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805912
[TBL] [Abstract][Full Text] [Related]
49. The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity.
Frigolet ME; Torres N; Tovar AR
J Nutr Biochem; 2013 Dec; 24(12):2003-15. PubMed ID: 24120291
[TBL] [Abstract][Full Text] [Related]
50. Adipose tissue dysfunction in obesity.
Blüher M
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
[TBL] [Abstract][Full Text] [Related]
51. MAP3K8 (TPL2/COT) affects obesity-induced adipose tissue inflammation without systemic effects in humans and in mice.
Ballak DB; van Essen P; van Diepen JA; Jansen H; Hijmans A; Matsuguchi T; Sparrer H; Tack CJ; Netea MG; Joosten LA; Stienstra R
PLoS One; 2014; 9(2):e89615. PubMed ID: 24586913
[TBL] [Abstract][Full Text] [Related]
52. Association between obesity, inflammation and insulin resistance: Insights into signaling pathways and therapeutic interventions.
Suren Garg S; Kushwaha K; Dubey R; Gupta J
Diabetes Res Clin Pract; 2023 Jun; 200():110691. PubMed ID: 37150407
[TBL] [Abstract][Full Text] [Related]
53. Skeletal glucocorticoid signalling determines leptin resistance and obesity in aging mice.
Henneicke H; Kim S; Swarbrick MM; Li J; Gasparini SJ; Thai J; Foong D; Cavanagh LL; Fong-Yee C; Karsten E; Lin RCY; Cooper MS; Zhou H; Seibel MJ
Mol Metab; 2020 Dec; 42():101098. PubMed ID: 33045434
[TBL] [Abstract][Full Text] [Related]
54. Obesity and cancer: the role of dysfunctional adipose tissue.
van Kruijsdijk RC; van der Wall E; Visseren FL
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2569-78. PubMed ID: 19755644
[TBL] [Abstract][Full Text] [Related]
55. Adipose tissue and metabolic and inflammatory responses to stroke are altered in obese mice.
Haley MJ; Mullard G; Hollywood KA; Cooper GJ; Dunn WB; Lawrence CB
Dis Model Mech; 2017 Oct; 10(10):1229-1243. PubMed ID: 28798136
[TBL] [Abstract][Full Text] [Related]
56. Getting the message across: mechanisms of physiological cross talk by adipose tissue.
Lee DE; Kehlenbrink S; Lee H; Hawkins M; Yudkin JS
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1210-29. PubMed ID: 19258492
[TBL] [Abstract][Full Text] [Related]
57. Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis.
Maher JJ; Leon P; Ryan JC
Hepatology; 2008 Aug; 48(2):670-8. PubMed ID: 18666225
[TBL] [Abstract][Full Text] [Related]
58. Adiponectin, Leptin and Cardiovascular Disorders.
Zhao S; Kusminski CM; Scherer PE
Circ Res; 2021 Jan; 128(1):136-149. PubMed ID: 33411633
[TBL] [Abstract][Full Text] [Related]
59. Prostacyclin: A major prostaglandin in the regulation of adipose tissue development.
Rahman MS
J Cell Physiol; 2019 Apr; 234(4):3254-3262. PubMed ID: 30431153
[TBL] [Abstract][Full Text] [Related]
60. Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance.
Nishimoto S; Fukuda D; Higashikuni Y; Tanaka K; Hirata Y; Murata C; Kim-Kaneyama JR; Sato F; Bando M; Yagi S; Soeki T; Hayashi T; Imoto I; Sakaue H; Shimabukuro M; Sata M
Sci Adv; 2016 Mar; 2(3):e1501332. PubMed ID: 27051864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
